CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer
Abstract Dysregulation of alternative splicing is a feature of cancer, both in aetiology and progression. It occurs because of mutations in splice sites or sites that regulate splicing, or because of the altered expression and activity of splice factors and of splice factor kinases that regulate spl...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1595aa359a334c009f784001b7ba6977 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|